LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1Shanghai Minbiotech
03 2BSP Pharmaceuticals
04 1Biosynergy Pharmaceutical
Reset all filters
01 2China
02 2Italy
03 1U.S.A
Reset all filters
01 5Blank
01 5Blank
Reset all filters
01 5Blank
Reset all filters
01 5Blank
Reset all filters
01 5Blank
Reset all filters
01 143624-040
02 143624-041
03 3Blank
01 5Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

NDC Package Code : 43624-040
Start Marketing Date : 2013-02-22
End Marketing Date : 2027-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING

NDC Package Code : 43624-041
Start Marketing Date : 2013-02-22
End Marketing Date : 2027-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING

We have 4 companies offering Trastuzumab Emtansine
Get in contact with the supplier of your choice: